Global In Silico Drug Discovery Market Overview And Scope:
Global In Silico Drug Discovery Market Size was estimated at USD 2232.75 million in 2022 and is projected to reach USD 4411.54 million by 2028, exhibiting a CAGR of 12.02% during the forecast period.
The Global In Silico Drug Discovery Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of In Silico Drug Discovery utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schr?dinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG)
Global In Silico Drug Discovery Market Segmentation
By Type, In Silico Drug Discovery market has been segmented into:Software as a Service (Cloud)
Consultancy as a Service
Software
In-
By Application, In Silico Drug Discovery market has been segmented into:
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The In Silico Drug Discovery market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the In Silico Drug Discovery market.
Top Key Players Covered in In Silico Drug Discovery market are:
Charles River
Certara USA
Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schr?dinger
Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Objective to buy this Report:
1. In Silico Drug Discovery analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with In Silico Drug Discovery market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: In Silico Drug Discovery Market by Type
5.1 In Silico Drug Discovery Market Overview Snapshot and Growth Engine
5.2 In Silico Drug Discovery Market Overview
5.3 Software as a Service (Cloud)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Software as a Service (Cloud): Geographic Segmentation
5.4 Consultancy as a Service
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Consultancy as a Service: Geographic Segmentation
5.5 Software
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Software: Geographic Segmentation
5.6 In-
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 In-: Geographic Segmentation
Chapter 6: In Silico Drug Discovery Market by Application
6.1 In Silico Drug Discovery Market Overview Snapshot and Growth Engine
6.2 In Silico Drug Discovery Market Overview
6.3 Contract Research Organization
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Contract Research Organization: Geographic Segmentation
6.4 Pharmaceutical Industry
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmaceutical Industry: Geographic Segmentation
6.5 Academic and Research Institutes
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Academic and Research Institutes: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 In Silico Drug Discovery Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 In Silico Drug Discovery Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 In Silico Drug Discovery Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 CHARLES RIVER
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CERTARA USA
7.4 INC.
7.5 EVOTEC
7.6 DASSAULT SYSTEM (BIOVIA)
7.7 ALBANY MOLECULAR RESEARCH INC. (AMRI)
7.8 SELVITA
7.9 SCHR?DINGER
7.10 INC.
7.11 GVK BIO
7.12 OPENEYE SCIENTIFIC SOFTWARE
7.13 CHEMICAL COMPUTING GROUP (CCG)
Chapter 8: Global In Silico Drug Discovery Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Software as a Service (Cloud)
8.2.2 Consultancy as a Service
8.2.3 Software
8.2.4 In-
8.3 Historic and Forecasted Market Size By Application
8.3.1 Contract Research Organization
8.3.2 Pharmaceutical Industry
8.3.3 Academic and Research Institutes
8.3.4 Others
Chapter 9: North America In Silico Drug Discovery Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Software as a Service (Cloud)
9.4.2 Consultancy as a Service
9.4.3 Software
9.4.4 In-
9.5 Historic and Forecasted Market Size By Application
9.5.1 Contract Research Organization
9.5.2 Pharmaceutical Industry
9.5.3 Academic and Research Institutes
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe In Silico Drug Discovery Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Software as a Service (Cloud)
10.4.2 Consultancy as a Service
10.4.3 Software
10.4.4 In-
10.5 Historic and Forecasted Market Size By Application
10.5.1 Contract Research Organization
10.5.2 Pharmaceutical Industry
10.5.3 Academic and Research Institutes
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe In Silico Drug Discovery Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Software as a Service (Cloud)
11.4.2 Consultancy as a Service
11.4.3 Software
11.4.4 In-
11.5 Historic and Forecasted Market Size By Application
11.5.1 Contract Research Organization
11.5.2 Pharmaceutical Industry
11.5.3 Academic and Research Institutes
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific In Silico Drug Discovery Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Software as a Service (Cloud)
12.4.2 Consultancy as a Service
12.4.3 Software
12.4.4 In-
12.5 Historic and Forecasted Market Size By Application
12.5.1 Contract Research Organization
12.5.2 Pharmaceutical Industry
12.5.3 Academic and Research Institutes
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa In Silico Drug Discovery Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Software as a Service (Cloud)
13.4.2 Consultancy as a Service
13.4.3 Software
13.4.4 In-
13.5 Historic and Forecasted Market Size By Application
13.5.1 Contract Research Organization
13.5.2 Pharmaceutical Industry
13.5.3 Academic and Research Institutes
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America In Silico Drug Discovery Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Software as a Service (Cloud)
14.4.2 Consultancy as a Service
14.4.3 Software
14.4.4 In-
14.5 Historic and Forecasted Market Size By Application
14.5.1 Contract Research Organization
14.5.2 Pharmaceutical Industry
14.5.3 Academic and Research Institutes
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
In Silico Drug Discovery Scope:
|
Report Data
|
In Silico Drug Discovery Market
|
|
In Silico Drug Discovery Market Size in 2025
|
USD XX million
|
|
In Silico Drug Discovery CAGR 2025 - 2032
|
XX%
|
|
In Silico Drug Discovery Base Year
|
2024
|
|
In Silico Drug Discovery Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schr?dinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG).
|
|
Key Segments
|
By Type
Software as a Service (Cloud)
Consultancy as a Service
Software
In-
By Applications
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
|
